SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mark A. Cervinski, Soya S. Sam, Heather B. Steinmetz, Brendan Wood, Gregory J. Tsongalis, Validation of interleukin 28B genotyping assay for clinical use, Clinical Biochemistry, 2014, 47, 6, 478

    CrossRef

  2. 2
    Srikanta Dash, Partha Chandra, Kurt Ramazan, Robert Garry, Luis Balart, Cancer-Causing Viruses and Their Inhibitors, 2014,

    CrossRef

  3. 3
    Arun B. Jesudian, Ype P. de Jong, Ira M. Jacobson, Emerging Therapeutic Targets for Hepatitis C Virus Infection, Clinical Gastroenterology and Hepatology, 2013, 11, 6, 612

    CrossRef

  4. 4
    K. Muller, A. Rodgers, R. Wundke, V. Waddell, R. Altus, D. L. Gordon, A. Wigg, Single centre experience with pegylated interferon and ribavirin for hepatitis C: looking back before moving forward, Internal Medicine Journal, 2012, 42, 7
  5. 5
    Noha G Bader El Din, Mai Abd El Meguid, Ashraf A Tabll, Mohamed A Anany, Gamal Esmat, Naglaa Zayed, Amr Helmy, Abdel Rahman El Zayady, Ahmed Barakat, Mostafa K El Awady, Human cytomegalovirus infection inhibits response of chronic hepatitis-C-virus-infected patients to interferon-based therapy, Journal of Gastroenterology and Hepatology, 2011, 26, 1
  6. 6
    Stephane Chevaliez, Tarik Asselah, Mechanisms of non-response to antiviral treatment in chronic hepatitis C, Clinics and Research in Hepatology and Gastroenterology, 2011, 35, S31

    CrossRef

  7. 7
    S. K. Tohra, S. Taneja, S. Ghosh, B. K. Sharma, A. Duseja, R. K. Dhiman, A. Das, Y. K. Chawla, Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C, Digestive Diseases and Sciences, 2011, 56, 8, 2449

    CrossRef

  8. 8
    Tomokazu Kawaoka, C. Nelson Hayes, Waka Ohishi, Hidenori Ochi, Toshiro Maekawa, Hiromi Abe, Masataka Tsuge, Fukiko Mitsui, Nobuhiko Hiraga, Michio Imamura, Shoichi Takahashi, Michaki Kubo, Tatsuhiko Tsunoda, Yusuke Nakamura, Hiromitsu Kumada, Kazuaki Chayama, Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b, Journal of Hepatology, 2011, 54, 3, 408

    CrossRef

  9. 9
    Ahmad Amanzada, Armin Goralczyk, Federico Moriconi, Martina Blaschke, Inga-Marie Schaefer, David van Thiel, Sabine Mihm, Giuliano Ramadori, Ultra-Rapid Virological Response, Young Age, Low γ-GT/ALT-Ratio, and Absence of Steatosis Identify a Subgroup of HCV Genotype 3 Patients Who Achieve SVR with IFN-α2a Monotherapy, Digestive Diseases and Sciences, 2011, 56, 11, 3296

    CrossRef

  10. 10
    Kiana Shahzamani, Shahin Merat, Houri Rezvan, Siamak Mirab-Samiee, Hooman Khademi, Reza Malekzadeh, Farzaneh Sabahi, Development of a low-cost real-time reverse transcriptase-polymerase chain reaction technique for the detection and quantification of hepatitis C viral load, Clinical Chemistry and Laboratory Medicine, 2010, 48, 6

    CrossRef

  11. 11
    Tarik Asselah, Emilie Estrabaud, Ivan Bieche, Martine Lapalus, Simon De Muynck, Michel Vidaud, David Saadoun, Vassili Soumelis, Patrick Marcellin, Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin, Liver International, 2010, 30, 9
  12. 12
    N. H. Nguyen, P. VuTien, R. T. Garcia, H. Trinh, H. Nguyen, K. Nguyen, B. Levitt, M. H. Nguyen, Response to pegylated interferon and ribavirin in Asian American patients with Chronic hepatitis C genotypes 1 vs 2/3 vs 6, Journal of Viral Hepatitis, 2010, 17, 10
  13. 13
    Nghia H. Nguyen, Philip VuTien, Huy N. Trinh, Ruel T. Garcia, Long H. Nguyen, Huy A. Nguyen, Khanh K. Nguyen, Mindie H. Nguyen, Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans, Hepatology International, 2010, 4, 2, 523

    CrossRef

  14. 14
    Michelle Martinot-Peignoux, Christiane Stern, Sarah Maylin, Marie-Pierre Ripault, Nathalie Boyer, Laurence Leclere, Corinne Castelnau, Nathalie Giuily, Ahmed El Ray, Ana-Carolina Cardoso, Rami Moucari, Tarik Asselah, Patrick Marcellin, Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin, Hepatology, 2010, 51, 4
  15. 15
    Hironobu Tsukada, Hidenori Ochi, Toshiro Maekawa, Hiromi Abe, Yoshifumi Fujimoto, Masataka Tsuge, Hiroshi Takahashi, Hiromitsu Kumada, Naoyuki Kamatani, Yusuke Nakamura, Kazuaki Chayama, A Polymorphism in MAPKAPK3 Affects Response to Interferon Therapy for Chronic Hepatitis C, Gastroenterology, 2009, 136, 5, 1796

    CrossRef

  16. 16
    Michelle Martinot-Peignoux, Hacène Khiri, Laurence Leclere, Sarah Maylin, Patrick Marcellin, Philippe Halfon, Clinical performances of two real-time PCR assays and bDNA/TMA to early monitor treatment outcome in patients with chronic hepatitis C, Journal of Clinical Virology, 2009, 46, 3, 216

    CrossRef

  17. 17
    P. Marcellin, Hépatite C : la guérison, Gastroentérologie Clinique et Biologique, 2009, 33, 8-9, 819

    CrossRef

  18. 18
    S.-T. Chen, Y.-H. Ni, P.-J. Chen, H.-L. Chen, Y.-M. Jeng, M.-Y. Lu, J.-F. Wu, H.-Y. Hsu, M.-H. Chang, Low viraemia at enrollment in children with chronic hepatitis C favours spontaneous viral clearance, Journal of Viral Hepatitis, 2009, 16, 11
  19. 19
    Eliza M. F. Berkley, Kimberly K. Leslie, Sanjeev Arora, Clifford Qualls, Jeffrey C. Dunkelberg, Chronic Hepatitis C in Pregnancy, Obstetrics & Gynecology, 2008, 112, 2, Part 1, 304

    CrossRef

  20. 20
    Hongju Mao, Zhimeng Lu, Honglian Zhang, Kangdong Liu, Jianlong Zhao, Gendi Jin, Shimin Gu, Mengsu Yang, Colorimetric oligonucleotide array for genotyping of hepatitis C virus based on the 5′ non-coding region, Clinica Chimica Acta, 2008, 388, 1-2, 22

    CrossRef

  21. 21
    Fathia Zaky El Sharkawi, Michael Chudy, Kay-Martin Hanschmann, Julia Kress, C. Micha Nübling, Consistency of quantitation of HCV genotype 4 from egypt across three HCV-RNA amplification assays, Journal of Medical Virology, 2008, 80, 12
  22. 22
    Y.-H. YEN, C.-H. HUNG, T.-H. HU, C.-H. CHEN, C.-M. WU, J.-H. WANG, S.-N. LU, C.-M. LEE, Mutations in the interferon sensitivity-determining region (nonstructural 5A amino acid 2209–2248) in patients with hepatitis C-1b infection and correlating response to combined therapy of pegylated interferon and ribavirin, Alimentary Pharmacology & Therapeutics, 2008, 27, 1
  23. 23
    Deepak Kumar, Abdul Malik, Mohammad Asim, Anita Chakravarti, Rakha H. Das, Premashis Kar, Response of Combination Therapy on Viral Load and Disease Severity in Chronic Hepatitis C, Digestive Diseases and Sciences, 2008, 53, 4, 1107

    CrossRef

  24. 24
    K. Sandres-Sauné, F. Abravanel, F. Nicot, J.M. Peron, L. Alric, J. Boineau, C. Pasquier, J. Izopet, Detection and quantitation of HCV RNA using real-time PCR after automated sample processing, Journal of Medical Virology, 2007, 79, 12
  25. 25
    Esteban Domingo, Jordi Gomez, Quasispecies and its impact on viral hepatitis, Virus Research, 2007, 127, 2, 131

    CrossRef

  26. 26
    Saburo Sone, Akiko Izawa, Hideki Narumi, Akemi Kajita, Junichi Tanabe, Fumihiro Taguchi, The combination of type I interferon and ribavirin has an inhibitory effect on mouse hepatitis virus infection, Hepatology Research, 2007, 37, 2
  27. 27
    Tarik Asselah, Hamza Boudjema, Claire Francoz, Rodolphe Sobesky, Dominique Valla, Jacques Belghiti, Patrick Marcellin, François Durand, Hépatite C et transplantation hépatique, Gastroentérologie Clinique et Biologique, 2006, 30, 11, 1281

    CrossRef

  28. 28
    Chia-Yen Dai, Wan-Long Chuang, Ming-Yen Hsieh, Li-Po Lee, Nai-Jen Hou, Shinn-Cherng Chen, Zu-Yau Lin, Ming-Yuh Hsieh, Liang-Yen Wang, Jun-Fa Tsai, Wen-Yu Chang, Ming-Lung Yu, Polymorphism of interferon–gamma gene at position +874 and clinical characteristics of chronic hepatitis C, Translational Research, 2006, 148, 3, 128

    CrossRef

  29. 29
    Konstantinos C. Thomopoulos, George J. Theocharis, Athanasios C. Tsamantas, Dimitrios Siagris, Dimitra Dimitropoulou, Charalambos A. Gogos, Chrysoula Labropoulou-Karatza, Liver steatosis is an independent risk factor for treatment failure in patients with chronic hepatitis C, European Journal of Gastroenterology & Hepatology, 2005, 17, 2, 149

    CrossRef

  30. 30
    Ivan Bièche, Tarik Asselah, Ingrid Laurendeau, Dominique Vidaud, Claude Degot, Valérie Paradis, Pierre Bedossa, Dominique-Charles Valla, Patrick Marcellin, Michel Vidaud, Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection, Virology, 2005, 332, 1, 130

    CrossRef

  31. 31
    Chia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, Shinn-Cherng Chen, Li-Po Lee, Ming-Yen Hsieh, Nei-Jen Hou, Zu-Yau Lin, Ming-Yuh Hsieh, Liang-Yen Wang, Ming-Lung Yu, Polymorphisms in the interferon-γ gene at position +874 in patients with chronic hepatitis C treated with high-dose interferon-α and ribavirin, Antiviral Research, 2005, 67, 2, 93

    CrossRef

  32. 32
    Graham R. Foster, Abid R. Suddle, Treatment of HCV infection with pegylated interferons, Current Hepatitis Reports, 2005, 4, 2, 49

    CrossRef

  33. 33
    P. Veillon, C. Payan, C. Gaudy, A. Goudeau, F. Lunel, Analyse des mutations des domaines ISDR et V3 de la protéine NS5A du virus de l'hépatite C avant le traitement par l'interféron avec ou sans ribavirine, Pathologie Biologie, 2004, 52, 9, 505

    CrossRef

  34. 34
    Sidhartha Hazari, Subrat Kumar Acharya, Subrat Kumar Panda, Development and evaluation of a quantitative competitive reverse transcription polymerase chain reaction (RT-PCR) for hepatitis C virus RNA in serum using transcribed thio-RNA as internal control, Journal of Virological Methods, 2004, 116, 1, 45

    CrossRef

  35. 35
    Bin Gao, Feng Hong, Svetlana Radaeva, Host factors and failure of interferon-α treatment in hepatitis C virus, Hepatology, 2004, 39, 4
  36. 36
    Françoise Lunel, Pascal Veillon, Isabelle Fouchard-Hubert, Véronique Loustaud-Ratti, Armand Abergel, Christine Silvain, Hervé Rifflet, Alain Blanchi, Xavier Causse, Yannick Bacq, Christopher Payan, Antiviral effect of ribavirin in early non-responders to interferon monotherapy assessed by kinetics of hepatitis C virus RNA and hepatitis C virus core antigen, Journal of Hepatology, 2003, 39, 5, 826

    CrossRef

  37. 37
    Mayte Pérez-Olmeda, Marina Núñez, Miriam Romero, Juan González, Angeles Castro, José Ramón Arribas, José Pedreira, Pablo Barreiro, Javier García-Samaniego, Luz Martín-Carbonero, Inmaculada Jiménez-Nácher, Vincent Soriano, Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients, AIDS, 2003, 17, 7, 1023

    CrossRef

  38. 38
    Christine Brennan, Treatment of Hepatitis C Virus in the Coinfected Patient, Journal of the Association of Nurses in AIDS care, 2003, 14, 5, 52S

    CrossRef

  39. 39
    A Scott Muerhoff, George J. Dawson, Viral Hepatitis: Molecular Biology, Diagnosis, Epidemiology and Control, 2003,

    CrossRef

  40. 40
    Xuefeng Liu, Raymond F. Schinazi, Frontiers in Viral Hepatitis, 2003,

    CrossRef

  41. 41
    Karen R. Jacobson, Karen Murray, Aglaia Zellos, Kathleen B. Schwarz, An Analysis of Published Trials of Interferon Monotherapy in Children With Chronic Hepatitis C, Journal of Pediatric Gastroenterology and Nutrition, 2002, 34, 1, 52

    CrossRef

  42. 42
    Hideji Hanabusa, Efficacy of Induction Therapy with High-Dose Interferon for Patients with Hemophilia and Human Immunodeficiency Virus–Hepatitis C Virus Coinfection, Clinical Infectious Diseases, 2002, 35, 12, 1527

    CrossRef

  43. 43
    R. Vega Palomares, R. Planas Vilà, R. Durández Lazaro, S. Fábregas Puigtió, Hepatitis C aguda: respuesta al tratamiento combinado con interferón alfa más ribavirina, Gastroenterología y Hepatología, 2002, 25, 8, 483

    CrossRef

  44. 44
    Flavio Lirussi, Alessandro Beccarello, Giulia Castiglione, Antonio Guglietta, Impaired natural killer cell cytotoxic activity in chronic hepatitis C viral infection: A single-center, controlled study, Current Therapeutic Research, 2002, 63, 11, 748

    CrossRef

  45. 45
    Samuel S Lee, E.Jenny Heathcote, K.Rajender Reddy, Stefan Zeuzem, Michael W Fried, Teresa L Wright, Paul J Pockros, Dieter Häussinger, Coleman I Smith, Amy Lin, Stephen C Pappas, Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD), Journal of Hepatology, 2002, 37, 4, 500

    CrossRef

  46. 46
    Muriel Soler, Muriel Pellerin, Cécile E. Malnou, Daniel Dhumeaux, Katherine M. Kean, Jean-Michel Pawlotsky, Quasispecies Heterogeneity and Constraints on the Evolution of the 5′ Noncoding Region of Hepatitis C Virus (HCV): Relationship with HCV Resistance to Interferon-α Therapy, Virology, 2002, 298, 1, 160

    CrossRef

  47. 47
    Ji-Hong Yang, Jian-Ping Lai, Steven D. Douglas, David Metzger, Xian-Hua Zhu, Wen-Zhe Ho, Real-time RT-PCR for quantitation of hepatitis C virus RNA, Journal of Virological Methods, 2002, 102, 1-2, 119

    CrossRef

  48. 48
    Takayoshi Fukutomi, Makoto Nakamuta, Marie Fukutomi, Masataka Iwao, Hironobu Watanabe, Kaichiro Hiroshige, Yuichi Tanabe, Hajime Nawata, Decline of hepatitis C virus load in serum during the first 24 h after administration of interferon-beta as a predictor of the efficacy of therapy, Journal of Hepatology, 2001, 34, 1, 100

    CrossRef

  49. 49
    Fco J Castro, Silvia Sauleda, J.I Esteban, L Viladomiu, M Martell, E Dragon, R Esteban, J Guardia, Evaluation of hepatitis C virus RNA RT/PCR qualitative and quantitative second generation assays, Journal of Virological Methods, 2001, 91, 1, 51

    CrossRef

  50. 50
    Kazuaki Chayama, Fumitaka Suzuki, Akihito Tsubota, Norio Akuta, Takashi Someya, Masahiro Kobayashi, Yasuji Arase, Satoshi Saitoh, Yoshiyuki Suzuki, Kenji Ikeda, Hiromitsu Kumada, Evaluation of quantitative measurements of hepatitis C virus RNA to predict sustained response to interferon by genotype, Journal of Virological Methods, 2001, 95, 1-2, 33

    CrossRef

  51. 51
    Alberto R. Osella, Giovanni Misciagna, Vito Guerra, Silvana Elba, Giampiero Buongiorno, Aldo Cavallini, Alfredo Di Leo, Laura Sonzogni, Mario U. Mondelli, Enrico M. Silini, Hepatitis C Virus Genotypes and Risk of Cirrhosis in Southern Italy, Clinical Infectious Diseases, 2001, 33, 1, 70

    CrossRef

  52. 52
    Emilia Hadziyannis, Alexandros Hadziyannis, Belinda Yen-Lieberman, Michelle L. Kiwi, Sandra Hodnick, Fotini Spanou, Colleen Starkey, Zobair M. Younossi, Hepatitis C Virus RNA Assays, Journal of Clinical Gastroenterology, 2001, 33, 1, 45

    CrossRef

  53. 53
    L. Mazzoran, F. Zorat, L. Chemello, L.S. Crocè, I. Rigato, L. Cavalletto, E. Bernardinello, C. Tiribelli, A. Alberti, G. Pozzato, Human leucocyte interferon-alpha in the treatment of chronic hepatitis C, Digestive and Liver Disease, 2001, 33, 4, 347

    CrossRef

  54. 54
    P. Andreone, A. Gramenzi, C. Cursaro, M. Biselli, L. Di Giammarino, G.L. Grazil, E. Jovine, A. D'Errico, S. Galli, A. Mazziotti, A. Cavallari, M. Bernardi, Interferon-alpha plus ribavirin and amantadine in patients with post-transplant hepatitis C: results of a pilot study, Digestive and Liver Disease, 2001, 33, 8, 693

    CrossRef

  55. 55
    Jae Sung Ko, Yon Ho Choe, Eun Joo Kim, Eun Hee Lee, Ja-June Jang, Jeong Kee Seo, Interferon-α Treatment of Chronic Hepatitis C in Children with Hemophilia, Journal of Pediatric Gastroenterology and Nutrition, 2001, 32, 1, 41

    CrossRef

  56. 56
    Fabien Zoulim, Quantification and genotyping in management of chronic hepatitis B and C, Virus Research, 2001, 82, 1-2, 45

    CrossRef

  57. 57
    Anne Gervais, Michèle Martinot, Nathalie Boyer, Anne Auperin, Véronique Le Breton, Claude Degott, Dominique Valla, Patrick Marcellin, Quantitation of hepatic hepatitis C virus RNA in patients with chronic hepatitis C. Relationship with severity of disease, viral genotype and response to treatment, Journal of Hepatology, 2001, 35, 3, 399

    CrossRef

  58. 58
    Yasushi Shiratori, Alan S. Perelson, Leor Weinberger, Fumio Imazeki, Osamu Yokosuka, Ryo Nakata, Masashi Ihori, Katsutaro Hirota, Naomi Ono, Hisamoto Kuroda, Teiji Motojima, Masaru Nishigaki, Masao Omata, Different turnover rate of hepatitis C virus clearance by different treatment regimen using interferon-beta, Journal of Hepatology, 2000, 33, 2, 313

    CrossRef

  59. 59
    Antonio Bellobuono, Luca Mondazzi, Silvana Tempini, Federico Chiodo, Enrico Magliano, Lina Furione, Gaetano Idéo, Early addition of ribavirin to interferon in chronic hepatitis C not responsive to interferon monotherapy, Journal of Hepatology, 2000, 33, 3, 463

    CrossRef

  60. 60
    Sanaa M. Kamal, Mohamed A. Madwar, Thomas Peters, Ragaa Fawzy, Jens Rasenack, Letters to the Editor, Journal of Hepatology, 2000, 32, 1, 172

    CrossRef

  61. 61
    Nathalie Boyer, Patrick Marcellin, Pathogenesis, diagnosis and management of hepatitis C, Journal of Hepatology, 2000, 32, 98

    CrossRef

  62. 62
    Stefan Zeuzem, S. Victor Feinman, Jens Rasenack, E. Jenny Heathcote, Ming-Yang Lai, Edward Gane, John O'Grady, Jürg Reichen, Moises Diago, Amy Lin, Joseph Hoffman, Michael J. Brunda, Peginterferon Alfa-2a in Patients with Chronic Hepatitis C, New England Journal of Medicine, 2000, 343, 23, 1666

    CrossRef

  63. 63
    P. Halfon, P. Cacoub, Quantification virale du virus de l'hépatite C : présent et avenir, La Revue de Médecine Interne, 2000, 21, 2, 174

    CrossRef

  64. 64
    G. Inchauspé, Réponses et mécanismes immunitaires liés aux infections par le virus de l'hépatite C, Médecine et Maladies Infectieuses, 2000, 30, S21

    CrossRef

  65. 65
    P. Colombatto, M. Baldi, F. Oliveri, A. Randone, F. Bonino, M.R. Brunetto, Tailoring interferon dose and monitoring viral load in hepatitis C virus genotype 1b infected patients: a pilot study, Digestive and Liver Disease, 2000, 32, 3, 211

    CrossRef

  66. 66
    John G. McHutchison, Thierry Poynard, Stephen Pianko, Stuart C. Gordon, Andrea E. Reid, Jules Dienstag, Timothy Morgan, Ruji Yao, Janice Albrecht, The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C, Gastroenterology, 2000, 119, 5, 1317

    CrossRef

  67. 67
    Jean-Michel Pawlotsky, Hepatitis C, 2000,

    CrossRef

  68. 68
    Mitchell L. Shiffman, Charlotte M. Hofmann, Melissa J. Contos, Velimir A. Luketic, Arun J. Sanyal, Richard K. Sterling, Andrea Ferreira-Gonzalez, A.Scott Mills, Carlton Garret, A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia, Gastroenterology, 1999, 117, 5, 1164

    CrossRef

  69. 69
    Peter Schmid, Myron Tong, Andrew Conrad, John McHutchison, Lawrence M. Blatt, Analysis of the viability of freezer stored serum samples for hepatitis C virus RNA analysis by the SUPERQUANT® method: results of a 16 year retrospective study, Journal of Virological Methods, 1999, 82, 2, 201

    CrossRef

  70. 70
    Andreas Ambrosch, Wolfgang König, Charakteristika des Hepatitis-C-Virus und virale Prädiktoren der therapeutischen Intervention, Medizinische Klinik, 1999, 94, 11, 626

    CrossRef

  71. 71
    Elizabeth Kenny-Walsh, Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin, New England Journal of Medicine, 1999, 340, 16, 1228

    CrossRef

  72. 72
    Mario U. Mondelli, Enrico Silini, Clinical significance of hepatitis C virus genotypes, Journal of Hepatology, 1999, 31, 65

    CrossRef

  73. 73
    Chihiro Morishima, David R. Gretch, CLINICAL USE OF HEPATITIS C VIRUS TESTS FOR DIAGNOSIS AND MONITORING DURING THERAPY, Clinics in Liver Disease, 1999, 3, 4, 717

    CrossRef

  74. 74
    Gary L. Davis, COMBINATION TREATMENT WITH INTERFERON AND RIBAVIRIN FOR CHRONIC HEPATITIS C, Clinics in Liver Disease, 1999, 3, 4, 811

    CrossRef

  75. 75
    Makoto Oketani, Takanori Higashi, Narihiro Yamasaki, Koichi Shinmyozu, Mitsuhiro Osame, Terukatsu Arima, Complete Response to Twice-a-Day Interferon-Beta with Standard Interferon-Alpha Therapy in Acute Hepatitis C After a Needle-Stick, Journal of Clinical Gastroenterology, 1999, 28, 1, 49

    CrossRef

  76. 76
    Jean-Michel Pawlotsky, Conduite à tenir devant une sérologie d'hépatite C positive, Revue Française des Laboratoires, 1999, 1999, 312, 144

    CrossRef

  77. 77
    Junya Murase, Shoji Kubo, Shuhei Nishiguchi, Kazuhiro Hirohashi, Taichi Shuto, Takashi Ikebe, Hiroaki Kinoshita, Correlation of Clinicopathologic Features of Resected Hepatocellular Carcinoma with Hepatitis C Virus Genotype, Japanese Journal of Cancer Research, 1999, 90, 12
  78. 78
    Maria-Pilar Civeira, Jesus Prieto, Early predictors of response to treatment in patients with chronic hepatitis C, Journal of Hepatology, 1999, 31, 237

    CrossRef

  79. 79
    Kimihide Nakamura, Masashi Yoneda, Shujiro Takamoto, Yukiomi Nakade, Shiro Yokohama, Keisuke Tamori, Kazunobu Aso, Tomoko Matui, Yoichi Sato, Masaru Aoshima, Isao Makino, Effect of ursodeoxycholic acid on autoimmune-associated chronic hepatitis C, Journal of Gastroenterology and Hepatology, 1999, 14, 5
  80. 80
    Vincent Soriano, Javier Garcìa-Samaniego, Rafael Rodrìguez-Rosado, Juan Gonzàlez, José Pedreira, Hepatitis C and HIV infection: biological, clinical, and therapeutic implications, Journal of Hepatology, 1999, 31, 119

    CrossRef

  81. 81
    Masafumi Komatsu, Toshiyuki Suto, Kazuyoshi Ishikawa, Shunichi Sato, High-dose natural interferon-α therapy for chronic hepatitis C with a high viral load: Predictors of efficacy, Journal of Gastroenterology and Hepatology, 1999, 14, 7
  82. 82
    Hiroshi Yatsuhashi, Tatsuya Fujino, Takenori Matsumoto, Osami Inoue, Michiaki Koga, Michitami Yano, Immunohistochemical analysis of hepatic interferon alpha-beta receptor level: relationship between receptor expression and response to interferon therapy in patients with chronic hepatitis C, Journal of Hepatology, 1999, 30, 6, 995

    CrossRef

  83. 83
    R. A. Willson, S. H. Fischer, H. D. Ochs, Long-Term Interferon Alpha Maintenance Therapy for Chronic Hepatitis C Infection in a Patient With Common Variable Immune Deficiency, Journal of Clinical Gastroenterology, 1999, 29, 2, 203

    CrossRef

  84. 84
    Giovanni Squadrito, Maria Elena Orlando, Irene Cacciola, Maria Grazia Rumi, Marco Artini, Antonio Picciotto, Oreste Loiacono, Rocco Siciliano, Massimo Levrero, Giovanni Raimondo, Long-term response to interferon alpha is unrelated to“interferon sensitivity determining region” variability in patients with chronic hepatitis C virus-1b infection, Journal of Hepatology, 1999, 30, 6, 1023

    CrossRef

  85. 85
    Pasqualina Pensati, Raffaele Iorio, Salvatore Botta, Concetta Tuccillo, Sara Donetto, Pietro Vajro, Giuseppina Ciarlo, Angela Vegnente, Low virological response to interferon in children with chronic hepatitis C, Journal of Hepatology, 1999, 31, 4, 604

    CrossRef

  86. 86
    Vincent Soriano, Rafael Rodríguez-Rosado, Javier García-Samaniego, Management of chronic hepatitis C in HIV-infected patients, AIDS, 1999, 13, 5, 539

    CrossRef

  87. 87
    Aijaz Ahmed, Emmet B. Keeffe, OVERVIEW OF INTERFERON THERAPY FOR CHRONIC HEPATITIS C, Clinics in Liver Disease, 1999, 3, 4, 757

    CrossRef

  88. 88
    NANCY L. ERIKSEN, Perinatal Consequences of Hepatitis C, Clinical Obstetrics and Gynecology, 1999, 42, 1, 121

    CrossRef

  89. 89
    G. Colloredo, L. Roffi, M. R. Brunetto, G. Leandro, B. Brugnetti, F. Bissoli, A. Scalori, G. Mancia, E. Civardi, G. Idéo, F. Bonino, G. Bellati, Prediction of relapse or sustained response in biochemical responders by serum hepatitis C virus RNA monitoring during interferon therapy, Journal of Viral Hepatitis, 1999, 6, 5
    Direct Link:
  90. 90
    Eleanor Barnes, George Webster, Simon Whalley, Geoffrey Dusheiko, PREDICTORS OF A FAVORABLE RESPONSE TO ALPHA INTERFERON THERAPY FOR HEPATITIS C, Clinics in Liver Disease, 1999, 3, 4, 775

    CrossRef

  91. 91
    Jean-Michel Pawlotsky, Michèle Martinot-Peignoux, Jean-Dominique Poveda, Anne Bastie, Véronique Le Breton, Françoise Darthuy, Jocelyne Rémiré, Serge Erlinger, Daniel Dhumeaux, Patrick Marcellin, Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays, Journal of Virological Methods, 1999, 79, 2, 227

    CrossRef

  92. 92
    Chiara Azzari, Massimo Resti, Flavia Bortolotti, Maria Moriondo, Carlo Crivellaro, Paolo Lionetti, Alberto Vierucci, Serum Levels of Hepatitis C Virus RNA in Infants and Children with Chronic Hepatitis C, Journal of Pediatric Gastroenterology & Nutrition, 1999, 29, 3, 314

    CrossRef

  93. 93
    Antonio Bellobuono, Luca Mondazzi, Silvana Tempini, Federico Chiodo, Enrico Magliano, Chiara Mondini, Gaetano Idéo, Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months?, Journal of Hepatology, 1999, 30, 1, 8

    CrossRef

  94. 94
    Laurent Alric, Jacques Izopet, Marylise Fort, Jean-Pierre Vinel, Patrick Fontenelle, Claudine Orfila, Jean-Louis Payen, K Sandres, Herve Desmorat, Jean-Paul Charlet, Michel Duffaut, Michel Abbal, Study of the association between major histocompatibility complex class II genes and the response to interferon alpha in patients with chronic hepatitis C infection, Human Immunology, 1999, 60, 6, 516

    CrossRef

  95. 95
    C. Silvain, Traitements antiviraux de l’infection par le virus de l’hépatite C, La Revue de Médecine Interne, 1999, 20, 331s

    CrossRef

  96. 96
    Flavia Bortolotti, Treatment of chronic hepatitis C in children, Journal of Hepatology, 1999, 31, 201

    CrossRef

  97. 97
    Gary L. Davis, Treatment of chronic hepatitis C: Impact of combination therapy, Current Gastroenterology Reports, 1999, 1, 1, 9

    CrossRef

  98. 98
    Veronique Duchatelle, Patrick Marcellin, Emile Giostra, Laurence Bregeaud, Michele Pouteau, Nathalie Boyer, Anne Auperin, Sylviane Guerret, Serge Erlinger, Dominique Henin, Claude Degott, Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric method, Journal of Hepatology, 1998, 29, 1, 20

    CrossRef

  99. 99
    Flavia Bortolotti, Massimo Resti, Raffaella Giacchino, Carlo Crivellaro, Lucia Zancan, Chiara Azzari, Nadia Gussetti, Loredana Tasso, Stefania Faggion, Changing epidemiologic pattern of chronic hepatitis C virus infection in Italian children, The Journal of Pediatrics, 1998, 133, 3, 378

    CrossRef

  100. 100
    Johannes T. Brouwer, Frederik Nevens, Bernhard Kleter, Andre Elewaut, Michael Alder, Reginald Brenard, Rob A.F.M. Chamuleau, Peter P. Michielsen, Jean Pirotte, Marc L. Hautekeete, Joseph Weber, Nadine Bourgeois, Bettina E. Hansen, Carolien M. Bronkhorst, Fibo J.W. ten Kate, Rudolf A. Heijtink, Johan Fevery, Solko W. Schalm, Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients, Journal of Hepatology, 1998, 28, 6, 951

    CrossRef

  101. 101
    Fujito Kageyama, Yoshimasa Kobayashi, Gou Murohisa, Erina Shimizu, Fumitaka Suzuki, Masataka Kikuyama, Kenichi Souda, Tsunehisa Kawasaki, Hirotoshi Nakamura, Failure to respond to interferon-α 2a therapy is associated with increased hepatic iron levels in patients with chronic hepatitis C, Biological Trace Element Research, 1998, 64, 1-3, 185

    CrossRef

  102. 102
    E. Spada, A.R. Ciccaglione, S. Dettori, P. Chionne, L.A. Kondili, P. Amoroso, V. Guadagnino, M. Greco, M. Rapicetta, Genotyping HCV isolates from Italy by type-specific PCR assay in the core region, Research in Virology, 1998, 149, 4, 209

    CrossRef

  103. 103
    A. Vince, D. Palmović, N. Kutela, Z. Sonicky, T. Jeren, M. Radovani, HCV genotypes in patients with chronic hepatitis C in Croatia, Infection, 1998, 26, 3, 173

    CrossRef

  104. 104
    Adrian M Di Bisceglie, Hepatitis C, The Lancet, 1998, 351, 9099, 351

    CrossRef

  105. 105
    Françoise Lunel, Lucile Musset, Hepatitis C virus infection and cryoglobulinemia, Journal of Hepatology, 1998, 29, 5, 848

    CrossRef

  106. 106
    Gary L. Davis, Rafael Esteban-Mur, Vinod Rustgi, John Hoefs, Stuart C. Gordon, Christian Trepo, Mitchell L. Shiffman, Stefan Zeuzem, Antonio Craxi, Mei-Hsiu Ling, Janice Albrecht, Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C, New England Journal of Medicine, 1998, 339, 21, 1493

    CrossRef

  107. 107
    MAUREEN M. JONAS, MARY JANE OTT, SUZANNE P. NELSON, KAMRAN BADIZADEGAN, ANTONIO R. PEREZ-ATAYDE, Interferon-alpha treatment of chronic hepatitis C virus infection in children, The Pediatric Infectious Disease Journal, 1998, 17, 3, 241

    CrossRef

  108. 108
    F. Piccinino, F.M. Felaco, E. Sagnelli, L. Aprea, V. Messina, G. Pasquale, P. Filippini, C. Scolastico, Long-term lymphoblastoid interferon-α therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFNα treatment, Research in Virology, 1998, 149, 5, 283

    CrossRef

  109. 109
    Lionel Frangeul, Pascale Cresta, Michele Perrin, Gilles Duverlie, Hafida Khorsi, Lucile Musset, Pierre Opolon, Jean-Marie Huraux, Françoise Lunel, Pattern of HCV antibodies with special reference to NS5A reactivity in HCV-infected patients: relation to viral genotype, cryoglobulinemia and response to interferon, Journal of Hepatology, 1998, 28, 4, 538

    CrossRef

  110. 110
    Stanislas Pol, Hélène Fontaine, Françoise Carnot, Hervé Zylberberg, Pierre Berthelot, Christian Bréchot, Bertrand Nalpas, Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients, Journal of Hepatology, 1998, 29, 1, 12

    CrossRef

  111. 111
    Michèle Martinot-Peignoux, Nathalie Boyer, Michèle Pouteau, Corinne Castelnau, Nathalie Giuily, Véronique Duchatelle, Anne Aupérin, Claude Degott, Jean-Pierre Benhamou, Serge Erlinger, Patrick Marcellin, Predictors of sustained response to alpha interferon therapy in chronic hepatitis C, Journal of Hepatology, 1998, 29, 2, 214

    CrossRef

  112. 112
    Olle Reichard, Gunnar Norkrans, Aril Frydén, Jean-Henrik Braconier, Anders Sönnerborg, Ola Weiland, Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C, The Lancet, 1998, 351, 9096, 83

    CrossRef

  113. 113
    Richard L Hodinka, The clinical utility of viral quantitation using molecular methods, Clinical and Diagnostic Virology, 1998, 10, 1, 25

    CrossRef

  114. 114
    C. A. Lee, C. M. Kessler, D. Varon, U. Martinowitz, M. Heim, G. M. DUSHEIKO, Therapy for chronic hepatitis B and C infection in haemophilia, Haemophilia, 1998, 4, 4
  115. 115
    A Bodson, E Mallaise, C Mauclet, C Mottry, D Thibe, Anticorps antivirus de l'hépatite C sur automate Access™: Un an d'expérience pratique en hôpital général, Immuno-analyse & Biologie Spécialisée, 1997, 12, 3, 130

    CrossRef

  116. 116
    Jörg F. Schlaak, Martin Trippler, Isabel Ernst, Karl-Hermann Meyer zum Büschenfelde, Guido Gerken, Chronic hepatitis C: the viral load per liver cell before treatment as a new marker to predict long-term response to IFN-α therapy, Journal of Hepatology, 1997, 27, 5, 917

    CrossRef

  117. 117
    Michael W. Fried, CLINICAL APPLICATION OF HEPATITIS C VIRUS GENOTYPING AND QUANTITATION, Clinics in Liver Disease, 1997, 1, 3, 631

    CrossRef

  118. 118
    Mercedes Pérez-Ruiz, Cristina Torres, Pedro A Garcı́a-López, Angela Ruiz-Extremera, Javier Salmerón, Alfredo Berzal-Herranz, Determination of HCV RNA concentration by direct quantitation of the products from a single RT-PCR, Journal of Virological Methods, 1997, 69, 1-2, 113

    CrossRef

  119. 119
    Sandrine Castelain, Hafida Khorsi, Patricia Zawadzki, Jean-Marie Sueur, Jean-Pierre Capron, François Eb, Gilles Duverlie, Direct blotting electrophoresis for sequencing and genotyping hepatitis C virus, Journal of Virological Methods, 1997, 65, 2, 237

    CrossRef

  120. 120
    Hafida Khorsi, Sandrine Castelain, Ann Wyseur, Jacques Izopet, Valérie Canva, Annelies Rombout, Dominique Capron, Jean-Pierre Capron, Françoise Lunel, Lieven Stuyver, Gilles Duverlie, Mutations of hepatitis C virus 1b NS5A 2209–2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients, Journal of Hepatology, 1997, 27, 1, 72

    CrossRef

  121. 121
    Giorgio Saracco, Elisabetta Borghesio, Pietro Mesina, Antonello Solinas, Claudia Spezia, Franco Macor, Vittorio Gallo, Livio Chiandussi, Carlo Donada, Valter Donadon, Fulvio Spirito, Alessandra Mangia, Angelo Andriulli, Giorgio Verme, Mario Rizzetto, Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon α-2b for chronic hepatitis type C, Journal of Hepatology, 1997, 27, 1, 56

    CrossRef

  122. 122
    D. Flichman, P. Colombatto, A. Randone, M. Baldi, G. Bellati, F. Negro, F. Oliveri, G. Colucci, G. Verme, F. Bonino, M.R. Brunetto, Quantitative detection of hepatitis C virus RNA in the serum of patients with chronic hepatitis C treated with interferon: A pilot study, Clinical and Diagnostic Virology, 1997, 8, 1, 63

    CrossRef

  123. 123
    Hideyuki Nomura, Akemi Kawasaki, Yuko Mizuno, Taki Kouyama, Mitsue Nakamura, Tsugie Iwao, The effect of plaunotol on stomatitis induced by interferon, Current Therapeutic Research, 1997, 58, 7, 428

    CrossRef

  124. 124
    Alastair J.J. Wood, Jay H. Hoofnagle, Adrian M. Di Bisceglie, The Treatment of Chronic Viral Hepatitis, New England Journal of Medicine, 1997, 336, 5, 347

    CrossRef

  125. 125
    Dominik M. Alscher, J. Christian Bode, Therapie der Hepatitis C, Medizinische Klinik, 1997, 92, 3, 147

    CrossRef

  126. 126
    C Trépo, P Merle, F Bailly, Traitements des hépatites C, La Revue de Médecine Interne, 1997, 18, s72

    CrossRef

  127. 127
    Gary L. Davis, TREATMENT OF ACUTE AND CHRONIC HEPATITIS C, Clinics in Liver Disease, 1997, 1, 3, 615

    CrossRef

  128. 128
    Eugene R. Schiff, F. Martin Tagle, TREATMENT OF HCV, Clinics in Liver Disease, 1997, 1, 3, 647

    CrossRef

  129. 129
    Silvio Magrin, Antonio Craxi, Carmelo Fabiano, Liliana Marino, Germana Fiorentino, Oreste Lo Iacono, Riccardo Volpes, Vito Di Marco, Piero Almasio, Alessandra Vaccaro, Mickey S. Urdea, Judith C. Wilber, Celestino Bonoura, Fabrizio Gianguzza, Vincenza Capursi, Salvatore Filiberti, Lieven Stuyver, Luigi Pagliaro, HCV viraemia is more important than genotype as a predictor of response to interferon in sicily (Southern Italy), Journal of Hepatology, 1996, 25, 5, 583

    CrossRef

  130. 130
    Donald B. Smith, Patrizia Pontisso, Heterogeneity of hepatitis C virus, Baillière's Clinical Gastroenterology, 1996, 10, 2, 243

    CrossRef

  131. 131
    Philippe Halfon, Hacène Khiri, Victoria Gerolami, Marc Bourliere, Jean M. Feryn, Pascal Reynier, André Gauthier, Guy Cartouzou, Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA, Journal of Hepatology, 1996, 25, 3, 307

    CrossRef

  132. 132
    Gary L. Davis, Interferon therapy for chronic hepatitis C, Baillière's Clinical Gastroenterology, 1996, 10, 2, 289

    CrossRef

  133. 133
    Michael W. Fried, THERAPY OF CHRONIC VIRAL HEPATITIS, Medical Clinics of North America, 1996, 80, 5, 957

    CrossRef

  134. 134
    P. Marcellin, Traitement des hépatites chroniques virales, Médecine et Maladies Infectieuses, 1996, 26, 4, 465

    CrossRef

  135. 135
    Anders Widell, Henrik Elmud, Mats Hugo Persson, Maimu Jonsson, Transmission of Hepatitis C via both Erythrocyte and Platelet Transfusions from a Single Donor in Serological Window-Phase of Hepatitis C, Vox Sanguinis, 1996, 71, 1
  136. 136
    Hari S. Conjeevaram, James E. Everhart, Jay H. Hoofnagle, Predictors of a sustained beneficial response to interferon alfa therapy in chronic hepatitis C, Hepatology, 1995, 22, 4